IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q3 2022 Holdings

Filed 2022-11-09 | 18 holdings | $37.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acumen Pharmaceuticals, Inc(ABOS)COM00509G209$34.3M3,417,07591.9%
Candel Therapeutics, Inc(CADL)COM137404109$2.5M811,7376.8%
Absci Corp.(ABSI)COM00091E109$181.0K57,8040.5%
Dice Therapeutics, Inc.COM23345J104$63.9K3,148,9700.2%
Uipath Inc(PATH)COM CL A90364P105$48.1K3,811,7790.1%
NU Holdings Ltd.(NU)COM CL AG6683N103$40.2K9,136,8350.1%
Snowflake Inc(SNOW)COM CL A833445109$36.5K214,6210.1%
Samsara, Inc.COM CL BFDS1Q2O30$32.7K2,712,2560.1%
Doordash Inc(DASH)COM CL A25809K105$29.7K601,4540.1%
10X Genomics, Inc.(TXG)COM CL A88025U109$13.7K481,7700.0%
Karuna Therapeutics, Inc.COM48576A100$13.2K58,8950.0%
Olink Holding ABCOM680710100$8.6K705,5140.0%
908 Devices Inc(MASS)COM65443P102$5.4K326,4270.0%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$4.5K260,0000.0%
Repligen Corp.(RGEN)COM759916109$4.2K22,5440.0%
Samsara, Inc.(IOT)COM CL A79589L106$3.9K326,0000.0%
Taysha Gene Therapies Inc(TSHA)COM877619106$1.4K724,8730.0%
Spruce Biosciences IncCOM85209E109$1.1K787,0070.0%